Literature DB >> 22358526

Factors limiting the commercial application of animal cells in culture.

R E Spier1.   

Abstract

The application of quality control and assurance procedures to the components of animal cell cultures has transformed what was an art to a viable industrial technology. This results in the successful large scale operation of such cultures. However it is clear that the cost of obtaining a license to produce materials from animal cells in culture severely impedes the movement of products into the market place. It is therefore necessary to examine in more detail the reasons for the reluctance of the regulatory authorities to issue product licences and in particular to appreciate the way ethical issues influence this process. This paper reviews these issues and indicates a way ahead.

Year:  1997        PMID: 22358526      PMCID: PMC3449875          DOI: 10.1023/A:1007975904301

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  7 in total

1.  On the acceptability of biopharmaceuticals.

Authors:  Raymond Spier
Journal:  Sci Eng Ethics       Date:  1996-07       Impact factor: 3.525

2.  Are prescription drug prices high?

Authors:  P R Vagelos
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

3.  Design of a bubble-swarm bioreactor for animal cell culture.

Authors:  F Gudermann; D Lütkemeyer; J Lehmann
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

4.  Prediction of mechanical damage to animal cells in turbulence.

Authors:  C R Thomas; M al-Rubeai; Z Zhang
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

Review 5.  Faster evaluation of vital drugs.

Authors:  D A Kessler; K L Feiden
Journal:  Sci Am       Date:  1995-03       Impact factor: 2.142

6.  The description of a device which facilitates the oxygenation of microcarrier cultures.

Authors:  R E Spier; J P Whiteside
Journal:  Dev Biol Stand       Date:  1983

7.  Oxygen transfer properties of bubbles in animal cell culture media.

Authors:  S Zhang; A Handa-Corrigan; R E Spier
Journal:  Biotechnol Bioeng       Date:  1992-06-20       Impact factor: 4.530

  7 in total
  2 in total

1.  Development and improvement of a serum-free suspension process for the production of recombinant adenoviral vectors using HEK293 cells.

Authors:  Y S Tsao; R Condon; E Schaefer; P Lio; Z Liu
Journal:  Cytotechnology       Date:  2001-11       Impact factor: 2.058

2.  Obtaining cell proliferation for chromosome preparation in gill tissue culture of the oyster Crassostrea gigas.

Authors:  M Cornet
Journal:  Cytotechnology       Date:  2000-01       Impact factor: 2.058

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.